Showing results (1-10 of 141) with videos related to

Sort By:
Pageof 15
Expert Opinion on Investigational Drugs|August 20, 2014
Early investigational drugs that target epidermal growth factor receptors for the treatment of head and neck cancerGamze Ugurluer, Mahmut Ozsahin
Expert Opinion on Investigational Drugs|April 13, 2016
Current Role of Dacomitinib in Head and Neck CancerOlgun Elicin, Mahmut Ozsahin
Radiation Oncology (London, England)|January 16, 2010
Multidisciplinary approach of early breast cancer: the biology applied to radiation oncologyCéline Bourgier, Mahmut Ozsahin, David Azria
Bulletin Du Cancer|September 20, 2007
[Radio-chemotherapy in head and neck cancer (EGFR+)]Mahmut Ozsahin, Oscar Matzinger, Michel Zimmermann, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|February 19, 2004
A prospective study of salivary gland function in patients undergoing radiotherapy for squamous cell carcinoma of the oropharynxPeter Möller, Michel Perrier, Mahmut Ozsahin, et al.
Radiation Oncology (London, England)|May 26, 2006
The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implicationsMichel Zimmermann, Abderrahim Zouhair, David Azria, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|March 9, 2004
Combined modality treatment with full-dose chemotherapy and concomitant boost radiotherapy for advanced head and neck carcinomaJürg Kutter, Mahmut Ozsahin, Philippe Monnier, et al.
Expert Opinion on Investigational Drugs|February 15, 2019
Emerging patient-specific treatment modalities in head and neck cancer - a systematic reviewOlgun Elicin, Nikola Cihoric, Eugenia Vlaskou Badra, et al.
Bulletin Du Cancer|August 6, 2014
[Breast cancer: radiotherapy and estrogen signaling]Céline Bourgier, Claire Lemanski, Gilles Romieu, et al.
Translational Lung Cancer Research|November 2, 2019
Current landscape of palliative radiotherapy for non-small-cell lung cancerRaphael Jumeau, Florent Vilotte, André-Dante Durham, et al.
Pageof 15